Today in this blog we will try to know Morepen Lab Share Price Target 2025, 2026, 2027, To 2030 In this blog we are going to analyze the stock Morepen Laboratories Ltd of the Pharmaceuticals sector. In this blog we will do all the research of the company for you like what does the company do? How can the performance of the company be for 5 years? Future status of the company? You will find information about all this research in this blog.
After reading this blog, you will also get to know about the technical analysis along with fundamentals about Morepen Laboratories Ltd. From which you can find out whether you should invest in this company or not, so let’s try to know the company.
About Morepen Laboratories Ltd
Morepen Laboratories Ltd is a leading Indian pharmaceutical company engaged in the development, manufacturing, marketing and sale of pharmaceutical active ingredients (APIs), formulations and home healthcare products. The company offers its products in India, the United States and internationally.
The company manufactures a wide range of medicines, covering therapeutic categories such as antibiotics, gastrointestinal, respiratory, analgesics, antiallergic and neuropsychiatry. The company also manufactures active ingredients required for the manufacture of medicines.
The company also offers over-the-counter products under the Dr. Morepen brand.
The company was founded in 1984. The company is headquartered in India.
| Company Name | Morepen Laboratories Ltd |
| Market Cap | ₹ 4,212 Cr. |
| P/E | 32.1 |
| ROE (Return on equity) | 12.0 % |
| ROCE (Return on Capital Employed ) | 16.8 % |
| 52 Week High (10-Sep-2024) | ₹ 100.90 |
| 52 Week Low (14-Mar-2024) | ₹ 38.55 |
| DIV. YIELD | 0.00 % |
| Date of Listing | 24-Nov-1999 |
Morepen Lab last 5 Year Performance
If we talk about the returns of Morepen Laboratories Ltd (MOREPENLAB) share in the last few years, then the company has given 56.38% returns to its investors in the last 1 year (Dec 2023 – Dec 2024). And if we talk about 5 years, then it has given 389.55% returns to its investors which is quite good.
| 3 Month Returns | -11.46% |
| 1 Year’s Returns | 56.38% |
| 5 Year’s Returns | 389.55% |
| Sales growth 3 Years | 12.5 % |
| Sales growth 5 Years | 17.1 % |
| Return over 3 Years | 11.2 % |
| Return over 5 Years | 37.7 % |
Morepen Lab Share Price Target 2025-2030
| Year | Target 1 | Target 2 |
| 2025 | ₹120 | ₹150 |
| 2026 | ₹140 | ₹180 |
| 2027 | ₹160 | ₹210 |
| 2028 | ₹180 | ₹240 |
| 2029 | ₹200 | ₹270 |
| 2030 | ₹220 | ₹300 |
Morepen Lab Share Price Target 2025
Talking about the Morepen Lab Share Price Target 2025, our analysis has said that this stock can remain between ₹ 120 and ₹ 150 in 2025.
These targets are given after looking at the data of the past history of the stock. In this, fundamental analysis has been done along with technical analysis.
| Target 1 | Target 2 |
| ₹ 120 | ₹ 150 |
Morepen Lab Share Price Target 2026
If the demand in this industry and the sales of this company see an increase, then as per our research the share price of Morepen Laboratories Ltd may remain between ₹ 140 and ₹ 180 by 2026.
| Target 1 | Target 2 |
| ₹ 140 | ₹ 180 |
Read this also:- Finolex Industries Share Price Target
Morepen Lab Share Price Target 2027
These share targets have been derived by looking at the company’s past performance. If the company’s performance remains good, then according to our analysts, the target for Morepen Lab shares in 2027 can be between ₹ 160 and ₹ 210.
| Target 1 | Target 2 |
| ₹ 160 | ₹ 210 |
Morepen Lab Share Price Target 2028
By analyzing the trend and stock of the last few years, it is known that if we talk about the target of Morepen Lab share price in 2028, then it can be between ₹ 180 and ₹ 240.
| Target 1 | Target 2 |
| ₹ 180 | ₹ 240 |
Morepen Lab Share Price Target 2029
Looking at the history of the last 5 years and the fundamental analysis of the stock, it seems that in the coming years i.e. if we talk about the target of Morepen Lab Share in 2029, then ₹ 200 and ₹ 270 can be seen.
| Target 1 | Target 2 |
| ₹ 200 | ₹ 270 |
Morepen Lab Share Price Target 2030
The price of Morepen Lab stock can remain between ₹ 220 to ₹ 300 by 2030. This price can also go up or down, this price is told by analyzing the stock data of the last 5 years.
The price of the company’s stock depends on how the company performs in the coming time. You must take the help of your financial advisor before investing.
| Target 1 | Target 2 |
| ₹ 220 | ₹ 300 |
Morepen Lab Promoters Holding
Friends, before investing in any company, it is very important to see the holding of the company’s promoters because from this we get an idea that if the promoters of the company have maintained their holding and are not selling it, then the company is performing well and can perform well.
It is said that it is not good if promoter’s holding is less in any company but it is said that if the holdings of FIIs and DIIs are increasing then it is good.
If we talk about the promoters’ holding in this company, it is 35.66%. You will see below who else has a stake in it.
| Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
| Promoters | 38.38% | 38.22% | 38.22% | 35.66% |
| FIIs | 0.96% | 0.96% | 1.85% | 2.08% |
| DIIs | 1.07% | 2.93% | 2.15% | 1.69% |
| Government | 0.00% | 0.01% | 0.01% | 0.01% |
| Public | 59.59% | 57.88% | 57.76% | 60.57% |
Morepen Lab Peer Companies
- Sun Pharma.Inds.
- Cipla
- Mankind Pharma
- Dr Reddy’s Labs
- Lupin
- Zydus Lifesci.
- Aurobindo Pharma
- Alkem Lab
- Morepen Lab
Conclusion
We hope that you have got all the information about Morepen Lab Share Price Target 2025, 2026, 2027, To 2030 properly and how did you like our blog, please tell us by commenting and also tell us what are your thoughts about Morepen Laboratories Ltd. Do share this article with your friends.
Frequently Asked Questions FAQ’S
How much debt does Morepen Lab have?
As of today when we are posting this blog, Morepen Lab has a debt of ₹ 33.5 Cr.
What does Morepen Laboratories Ltd do?
Morepen Laboratories Ltd is a leading Indian pharmaceutical company engaged in the development, manufacturing, marketing and sale of pharmaceutical active ingredients (APIs), formulations and home healthcare products. The company offers its products in India, the United States and internationally.
Disclaimer : The information presented in this article is for educational and informational purposes only. We do not recommend buying or selling stocks. These predictions are based on our research and technical data, any uncertainty in the market may affect the stock price, so investors should do their own research before making investment decisions. We will not be responsible for any loss or damage caused by the use of this article.